| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.32B | 2.32B | 2.20B | 2.09B | 1.84B | 1.59B |
| Gross Profit | 1.22B | 1.22B | 1.19B | 1.11B | 972.79M | 805.04M |
| EBITDA | 965.86M | 965.96M | 872.88M | 788.00M | 610.36M | 581.08M |
| Net Income | 597.04M | 597.04M | 537.13M | 468.17M | 396.92M | 399.59M |
Balance Sheet | ||||||
| Total Assets | 4.30B | 4.30B | 4.06B | 3.96B | 4.01B | 2.22B |
| Cash, Cash Equivalents and Short-Term Investments | 337.65M | 337.65M | 492.60M | 457.65M | 536.49M | 717.85M |
| Total Debt | 1.56B | 1.56B | 1.57B | 1.84B | 2.22B | 866.25M |
| Total Liabilities | 2.12B | 2.12B | 2.14B | 2.34B | 2.68B | 1.21B |
| Stockholders Equity | 2.19B | 2.19B | 1.91B | 1.62B | 1.33B | 1.02B |
Cash Flow | ||||||
| Free Cash Flow | 617.45M | 617.45M | 614.66M | 584.79M | 487.12M | 493.90M |
| Operating Cash Flow | 726.26M | 726.26M | 700.34M | 645.57M | 538.28M | 555.23M |
| Investing Cash Flow | -392.77M | -392.77M | -144.32M | -95.39M | -2.03B | -135.99M |
| Financing Cash Flow | -407.82M | -407.82M | -560.85M | -632.02M | 1.34B | -322.71M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $149.55B | 35.91 | 12.57% | 0.77% | 9.04% | 21.35% | |
72 Outperform | $85.54B | 38.55 | 57.08% | 0.78% | 8.77% | 13.62% | |
70 Outperform | $10.26B | 17.61 | 29.13% | 1.64% | 5.39% | 11.56% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | $42.47B | 35.83 | ― | 1.29% | 9.02% | 3.45% | |
64 Neutral | $8.72B | 24.10 | 24.42% | 0.86% | 7.76% | 15.92% | |
61 Neutral | $346.21M | 16.30 | 21.59% | 3.46% | -4.99% | 6.15% |
Factset Research faces a significant business risk related to its internal control over financial reporting, as highlighted by a material weakness in its IT general controls. This deficiency, disclosed in their 2024 Annual Report, affects key financial processes and poses a threat to the accuracy and timeliness of their financial statements. The ongoing remediation efforts, expected to conclude in fiscal 2026, strain management and resources, with no guarantee of complete effectiveness. Failure to address these issues could undermine investor confidence, lead to legal challenges, and negatively impact the company’s stock price and market access.
The recent earnings call from FactSet Research revealed a strong performance for the fourth quarter and fiscal year 2025, marked by record-breaking organic ASV growth and significant investments in AI. While the company is strategically positioned for long-term success, challenges such as prolonged sales cycles, pricing pressures in certain regions, and secular headwinds in EMEA suggest a need for cautious optimism in the current market environment.
FactSet Research Systems Inc., a global financial digital platform and enterprise solutions provider, has reported its fourth quarter and fiscal year 2025 earnings, showcasing growth in revenues and strategic advancements. The company operates in the financial services sector, offering data and analytics solutions to buy-side and sell-side clients worldwide.
On September 16, 2025, FactSet announced the resignation of James J. McGonigle from its Board of Directors, effective December 1, 2025, with no disagreements cited. The same day, FactSet’s Board updated the company’s bylaws to enhance procedural mechanics for director elections. FactSet reported strong financial results for the fourth quarter and fiscal year 2025, with a notable increase in GAAP revenues and operating margins, driven by growth in institutional and wealth client segments. The company also provided guidance for fiscal 2026, projecting continued growth and emphasizing its strategic focus on AI and data-driven innovation.
The most recent analyst rating on (FDS) stock is a Hold with a $370.00 price target. To see the full list of analyst forecasts on Factset Research stock, see the FDS Stock Forecast page.